Farideh Jalilehvand is a Professor in the Department of Chemistry at the University of Calgary, Faculty of Science. Her research focuses on metal-based anticancer drug design, chemical speciation, and advanced spectroscopic techniques including synchrotron-based X-ray absorption (XAS) and X-ray fluorescence microscopy (XFM). She holds a PhD from Royal Institute of Technology (KTH) and Ochanomizu University, with postdoctoral training at Stanford University. Her educational background includes degrees from Sharif University of Technology (B.Sc., M.Sc.) and certifications in leadership, teaching, and diversity. She teaches courses in inorganic chemistry and coordinates the Jalilehvand Research Group, which investigates transition metal complexes' interactions with biological systems. Key research areas include: metal complex cytotoxicity, nuclear localization of dirhodium complexes in cancer cells, and structural analysis of metallothionein analogues using XAS/XFM. Her work bridges medicinal chemistry and materials science, with applications in drug delivery and environmental remediation. Awards: NSERC University Faculty Award (2003), Erasmus+ Staff Mobility for Teaching (2019) Strategic Initiatives: Active contributor to the University of Calgary's One Health initiative Publications: Over 60 peer-reviewed articles focusing on metal complexation mechanisms and spectroscopic applications Her teaching excellence has been recognized through multiple nominations, and she actively supervises graduate students in inorganic chemistry and medicinal chemistry research.









